[ET Net News Agency, 29 September 2021] SIMCERE PHARMA (02096) fell 1.27% to HK$7.
It hits an intra-day low of HK$7, hitting a historical low, and an intra-day high of
HK$7.09. The total shares traded was 470,998, with a value of HK$3.31m. The active
buy/sell ratio is 15:85, with net selling turnover of HK$2.26m. MERRILL LYNCH FE accounts
for greatest net responsive buying turnover of HK$322,603, with volume weighted average
price of HK$7.027. CREDIT SUISSE (HK) SEC accounts for greatest net responsive selling
turnover of HK$191,273, with volume weighted average price of HK$7.044. The stock has
fallen a combined 4.11% over the past 5 consecutive trading days.
The Hang Seng Index now fell 210 points, or 0.86% to 24,290; the Hang Seng China
Enterprises Index now fell 108 points, or 1.24% to 8,612; the Hang Seng TECH Index now
fell 176 points, or 2.84% to 6,054; with an overall turnover of HK$53.29b.
The SSE Composite Index now fell 81 points, or 2.26% to 3,520, with an overall turnover
of RMB309.64b.
The SZSE Component Index now fell 275 points, or 1.93% to 14,037, with an overall
turnover of RMB167.57b.
Basic Information
-------------------------------------------
Nominal 7.000 % Chg -1.27%
High 7.090 Low 7.000
Shares Tr 470,998 Turnover 3.31m
10-D SMA 7.209 %H.V 32.395
20-D SMA 7.492 VWAP 7.030
50-D SMA 8.370 RSI14 32.351
-------------------------------------------
Status: Hitting a historical low, active buy/sell ratio is 15:85, with net selling
turnover of HK$2.26m, falling a combined 4.11% over the past 5 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SIMCERE PHARMA (02096) 7.00 -1.27
SIHUAN PHARM (00460) 1.53 +4.79
CMS (00867) 13.68 -1.44
CSPC PHARMA (01093) 9.32 -0.64
SINO BIOPHARM (01177) 6.23 +0.16
SSY GROUP (02005) 3.85 -4.47
FOSUN PHARMA (02196) 39.50 -3.54
WUXI APPTEC (02359) 176.20 -2.38
HANSOH PHARMA (03692) 19.16 +1.27
PHARMARON (03759) 180.90 -3.98
-------------------------------------------------
(ed)